Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

908 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients.
Greinix HT, Linkesch W, Seifert M, Kubista E, Czerwenka K, Elahi F, Zielinski C, Hoecker P, Steger G, Schulenburg A, Neumeister G, Rabitsch W, Jakesz R, Kalhs P. Greinix HT, et al. Among authors: zielinski c. Acta Oncol. 2000;39(1):47-52. doi: 10.1080/028418600430969. Acta Oncol. 2000. PMID: 10752653 Clinical Trial.
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics.
Wagner TM, Möslinger RA, Muhr D, Langbauer G, Hirtenlehner K, Concin H, Doeller W, Haid A, Lang AH, Mayer P, Ropp E, Kubista E, Amirimani B, Helbich T, Becherer A, Scheiner O, Breiteneder H, Borg A, Devilee P, Oefner P, Zielinski C. Wagner TM, et al. Among authors: zielinski c. Int J Cancer. 1998 Jul 29;77(3):354-60. doi: 10.1002/(sici)1097-0215(19980729)77:3<354::aid-ijc8>3.0.co;2-n. Int J Cancer. 1998. PMID: 9663595
99m-Tc-tetrofosmin scintigraphy and breast cancer.
Berghammer P, Obwegeser R, Mülauer-Ertl S, Karanikas G, Wiltschke C, Kubista E, Sinzinger H, Zielinski C. Berghammer P, et al. Among authors: zielinski c. Gynecol Oncol. 1999 Apr;73(1):87-90. doi: 10.1006/gyno.1998.5310. Gynecol Oncol. 1999. PMID: 10094885 Review.
Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.
Wagner TM, Hirtenlehner K, Shen P, Moeslinger R, Muhr D, Fleischmann E, Concin H, Doeller W, Haid A, Lang AH, Mayer P, Petru E, Ropp E, Langbauer G, Kubista E, Scheiner O, Underhill P, Mountain J, Stierer M, Zielinski C, Oefner P. Wagner TM, et al. Among authors: zielinski c. Hum Mol Genet. 1999 Mar;8(3):413-23. doi: 10.1093/hmg/8.3.413. Hum Mol Genet. 1999. PMID: 9971877
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL.
Martin M, Zielinski C, Ruiz-Borrego M, Carrasco E, Turner N, Ciruelos EM, Muñoz M, Bermejo B, Margeli M, Anton A, Kahan Z, Csöszi T, Casas MI, Murillo L, Morales S, Alba E, Gal-Yam E, Guerrero-Zotano A, Calvo L, de la Haba-Rodriguez J, Ramos M, Alvarez I, Garcia-Palomo A, Huang Bartlett C, Koehler M, Caballero R, Corsaro M, Huang X, Garcia-Sáenz JA, Chacón JI, Swift C, Thallinger C, Gil-Gil M. Martin M, et al. Among authors: zielinski c. Ann Oncol. 2021 Apr;32(4):488-499. doi: 10.1016/j.annonc.2020.12.013. Epub 2020 Dec 29. Ann Oncol. 2021. PMID: 33385521 Free article. Clinical Trial.
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
Brodowicz T, Lang I, Kahan Z, Greil R, Beslija S, Stemmer SM, Kaufman B, Petruzelka L, Eniu A, Anghel R, Koynov K, Vrbanec D, Pienkowski T, Melichar B, Spanik S, Ahlers S, Messinger D, Inbar MJ, Zielinski C. Brodowicz T, et al. Among authors: zielinski c. Br J Cancer. 2014 Nov 25;111(11):2051-7. doi: 10.1038/bjc.2014.504. Epub 2014 Sep 30. Br J Cancer. 2014. PMID: 25268370 Free PMC article. Clinical Trial.
908 results